Although there is no concrete evidence, neurolysin is hypothesized to be involved in the pathology of human diseases such as epilepsy, angiogenesis, tumor growth, sepsis, stroke, and metabolic disorder, together with thimet oligopeptidase (THOP1) and a POP [132]. This evidence concerns the gene THOP1 and metabolic disease.